Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells

Journal of the National Cancer Institute

Volumn 86, Issue 12, 1994, Pages 913-920

  Dong, Zhongyun ^a   Radinsky, Robert ^a   Fan, Dominic ^a   Tsan, Rachel ^a   Bucana, Corazon D ^a   Wilmanns, Christoph ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; MESSENGER RNA; SODIUM CHLORIDE; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CANCER TRANSPLANTATION; COLON CARCINOMA; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; SKIN TUMOR; SUBCUTANEOUS TISSUE;

ANIMAL; CARCINOMA; CARRIER PROTEINS; COLONIC NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE; GENE EXPRESSION; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; P-GLYCOPROTEIN; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VERAPAMIL;

EID: 0028342711     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/86.12.913     Document Type: Article

References (47)

1. Fidler U: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50:6130-6138, 1990
2. van der Bliek AM, Borst P: Multidrug resistance. Adv Cancer Res 52:165-203, 1989
3. Germann UA, Pastan I, Gottesman MM: P-glycoproteins: mediators of multidrug resistance. Semin Cell Biol 4:63-76, 1993
4. Tsuruo T: Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 79:285-296, 1988
5. Belli JA, Zhang Y, Fritz P: Transfer of adriamycin resistance by fusion of Mr 170,000 P-glycoprotein to the plasma membrane of sensitive cells. Cancer Res 50:2191-2197, 1990
6. Bradley G, Juranka PF, Ling V: Mechanism of multidrug resistance. Biochim Biophys Acta 948:87-128, 1988
7. Rothenberg M, Ling V: Multidrug resistance: molecular biology and clinical relevance. J Natl Cancer Inst 81:907-910, 1989
8. Pastan I, Gottesman MM, Ueda K, et al: A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85:4486-4490, 1988
9. Croop JM, Gros P, Housman DE: Genetics of multidrug resistance. J Clin Invest 81:1303-1309, 1988
10. Kanamaru H, Kakehi Y, Yoshida O, et al: MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J Natl Cancer Inst 81:844-849, 1989
11. Kartner N, Riordan JR, Ling V: Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221:1285-1288, 1983
12. Chabner BA, Fojo A: Multidrug resistance: P-glycoprotein and its allies-the elusive foes. J Natl Cancer Inst 81:910-913, 1989
13. Raghu G, Pierre-Jerome M, Dordal MS, et al: P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line. Int J Cancer 53:804-811, 1993
14. Volm M, Mattem J, Pommerenke EW: Time course of MDR gene amplification during in vivo selection for doxorubicin-resistance and during reversal in murine leukemia L 1210. Anticancer Res 11:579-586, 1991
15. Goldstein LJ, Galski H, Fojo A, et al: Expression of a multidrug resistance geneinhuman cancers. J Natl Cancer Inst 81:116-124, 1989
16. Weinstein RS, Jakate SM, Dominguez JM, et al: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51:2720-2726, 1991
17. Fojo AT, Ueda K, Slamon DJ, et al: Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265-269,1987
18. Park JG, Kramer BS, Lai S, et al: Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 82:193-198, 1990
19. I Morrow CS, Cowan KH: Mechanisms and clinical significance of multidrug resistance. Oncology (Huntingt) 2:55-63, 1988.
20. Dalton WS, Grogan TM: Does P-glycoprotein predict response to chemotherapy, and if so, is there a reliable way to detect it? J Natl Cancer Inst 83:80-81, 1991
21. l Slack NF1, Brass ID: The influence of site of metastasis on tumour growth and response to chemotherapy. Br J Cancer 32:78-86, 1975
22. Donelli MG, Russo R, Garattini S: Selective chemotherapy in relation to the site of tumor transplantation. Int J Cancer 2:421-424, 1967
23. Teicher BA, Herman TS, Holden SA, et al: Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 247:1457-1461,1990
24. Wilmanns C, Fan D, O'Brian CA, et al: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52:98-104, 1992
25. Staroselsky AN, Fan D, O’Brian CA, et al: Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin. Cancer Res 50:7775-7780, 1990
26. Corbett TH, Griswold DP Jr, Roberts BJ, et al: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35:2434-2439, 1975
27. Schackert HK, Fidler U: Development of an animal model to study die biology of recurrent colorectal cancer originating from mesenteric lymph system metastasis. Int J Cancer 44:177-181, 1989
28. Morikawa K, Walker SM, Nakajima M, et al: The influence of organ environment on the growth, selection, and metastasis of human colon cancer cells in nude mice. Cancer Res 48:6863-6871, 1988
29. Fan D, Fidler U, Ward NE, et al: Stable expression of a cDNA encoding rat brain protein kinase C-f5I confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res 12:661-667, 1992
30. Tsuruo T, Iida H, Tsukagoshi S, et al: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972, 1981
31. Bucana CD, Giavazzi R, Nayar R, et al: Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants. Exp Cell Res 190:69-75, 1990
32. Wilmanns C, Fan D, O’Brian CA, et al: Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma cells by ectopic and orthotopic environments in nude mice. Int J Oncol 3:412-422,1993
33. Radinsky R, Bucana CD, Ellis LM, et al: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res 53:937-943, 1993
34. Radinsky R, Culp LA: Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression. Int J Cancer 48:148-159, 1991
35. Gros P, Croop J, Housman D: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371-380, 1986
36. Raymond M, Rose E, Housman DE, et al: Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol Cell Biol 10:1642-1651, 1990
37. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
38. Bradley G, Sharma R, Rajalakshmi S, et al: P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 52:5154-5161, 1992
39. Kramer R, Weber TK, Morse B, et al: Constitutive expression of multidrug resistance in human colorectal tumours and cell lines [published erratum appears in Br J Cancer 68:645, 1993]. Br J Cancer 67:959-968, 1993
40. Croop JM, Raymond M, Haber D, et al: The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9:1346-1350, 1989
41. Devault A, Gros P: Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10:1652-1663, 1990
42. I FIsu SI, Lodtstein L, Horwitz SB: Differential overexpression of tluee mdr gene family members in multidrug-resistant J774.2 cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. J Biol Chem 264:12053-12062, 1989
43. Gros P, Raymond M, Bell J, et al: Cloning and characterization of a second member of die mouse mdr gene family. Mol Cell Biol 8:2770-2778, 1988
44. Arceci RJ, Croop JM, Horwiiz SB, et al: The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85:4350-4354, 1988
45. Mizoguchi T, Yamada K, Furukawa T, et al: Expression of the MDRI gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 82:1679-1683,1990
46. Schuurhuis GJ, Broxterman HJ, de Lange JH, et al: Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-giy coprotein. Brl Cancer 64:857-861, 1991
47. Bradley G, Sharma R, Rajalalcshmi S, et al: P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 52:5154-516, 1992